Photoimmunotherapy Using Cationic and Anionic Photosensitizer-Antibody Conjugates against HIV Env-Expressing Cells
Different therapeutic strategies have been investigated to target and eliminate HIV-1-infected cells by using armed antibodies specific to viral proteins, with varying degrees of success. Herein, we propose a new strategy by combining photodynamic therapy (PDT) with HIV Env-targeted immunotherapy, a...
Main Authors: | Mohammad Sadraeian, Calise Bahou, Edgar Ferreira da Cruz, Luíz Mário Ramos Janini, Ricardo Sobhie Diaz, Ross W. Boyle, Vijay Chudasama, Francisco Eduardo Gontijo Guimarães |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/23/9151 |
Similar Items
-
Development of a red-shifted photosensitizer for near-infrared photoimmunotherapy of cancer
by: Yuto Goto, et al.
Published: (2024-04-01) -
In situ photoimmunotherapy is ineffective in treating deeply invasive squamous cell carcinoma
by: Tak-Wah Wong, et al.
Published: (2014-06-01) -
Photoinduced Photosensitizer–Antibody Conjugates Kill HIV Env-Expressing Cells, Also Inactivating HIV
by: Mohammad Sadraeian, et al.
Published: (2021-06-01) -
Highly versatile cancer photoimmunotherapy using photosensitizer-conjugated avidin and biotin-conjugated targeting antibodies
by: Naoto Shirasu, et al.
Published: (2019-11-01) -
Eligibility for Photoimmunotherapy in Patients with Unresectable Advanced or Recurrent Head and Neck Cancer and Changes before and after Systemic Therapy
by: Takeshi Shinozaki, et al.
Published: (2023-07-01)